Henry Schein Received Validation of Net-Zero Science-Based Targets

Company Commits to Science-Based Targets to Guide Pathway for Achieving Net-Zero Emissions by 2050

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Science Based Targets initiative (SBTi) has approved the Company’s near-term and long-term science-based emissions reduction targets and has verified Henry Schein’s net-zero science-based target by 2050.

“Having joined the Business Ambition for 1.5⁰C initiative in 2021, Henry Schein is pleased to fulfill our commitment to set net-zero emissions reduction targets. Sustainability is deeply rooted in our corporate culture, and we understand our role in mitigating our environmental impact, as climate change is one of today’s most important sustainability issues,” says Jennifer Kim Field, Chief Sustainability Officer at Henry Schein. “Our validated science-based targets bring us closer to realizing our Company’s mission to make the world healthier, together – which needs to be done in collaboration with health care professionals in order to have a healthier planet for healthier people.”

To achieve the near-term science-based targets, Henry Schein, Inc. commits to:

• Reduce absolute scope 1 GHG (greenhouse gas) emissions by 42% by 2030 from a 2022 base year
• Increase active annual sourcing of renewable electricity from 0% in 2022 to 100% by 2030
• Reduce scope 3 GHG emissions by 51.6% per million USD value added (gross profit) by 2030 from a 2022 base year.

The committed net-zero targets include:

• Reducing absolute scope 1 GHG emissions by 90% by 2050 from a 2022 base year
• Continuing active annual sourcing of 100% renewable electricity through 2030
• Reducing scope 3 GHG emissions by 97% per million USD value added (gross profit) by 2050 from a 2022 base year.

To learn more about Henry Schein’s sustainability and corporate citizenship efforts and to view the Company’s 2023 CARES report, please visit www.henryschein.com/corporatecitizenship.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.